{"id":"W2890444045","doi":"10.1016/j.ejca.2018.08.010","title":"Survival benefit, disease progression and quality-of-life outcomes of abiraterone acetate plus prednisone versus docetaxel in metastatic hormone-sensitive prostate cancer: A network meta-analysis","year":2018,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Abiraterone acetate; Prostate cancer; Oncology; Internal medicine; Prednisone; Hazard ratio; Randomized controlled trial; Cabazitaxel; Quality of life (healthcare); Androgen deprivation therapy; Enzalutamide; Cancer; Confidence interval; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01852008,0.003065857,0.01238014,0.003538115,0.0004721344,0.002582799,0.002039477,0.001714261,0.003281152],"category_scores_gemma":[0.02648231,0.001266645,0.04724795,0.003168192,0.0005428039,0.001280496,0.001558799,0.00232581,0.0003153828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002271224,"about_ca_system_score_gemma":0.001609513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008684155,"about_ca_topic_score_gemma":0.01187197,"domain_scores_codex":[0.9883345,0.008415627,0.00122992,0.001044784,0.0007175068,0.0002576753],"domain_scores_gemma":[0.9864556,0.01041791,0.001624535,0.0006531937,0.0005819083,0.000266883],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.008431156,0.00003746339,0.004703665,0.02718621,0.9518545,0.00006470501,0.00003438922,0.002052795,0.0001661116,0.00009588605,0.0003179939,0.005055178],"study_design_scores_gemma":[0.001974316,0.0003045569,0.002761836,0.001367666,0.9917966,0.0000358731,0.00001430382,0.001025413,0.00005952898,0.0002152934,0.000428663,0.00001592002],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0811352,0.9070061,0.005124941,0.001004808,0.0006251356,0.0009541779,0.002504071,0.0002089248,0.001436583],"genre_scores_gemma":[0.8772492,0.1121016,0.005124975,0.001041254,0.0003221048,0.001542042,0.001731263,0.00008019226,0.0008074656],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01852008,"threshold_uncertainty_score":0.09794468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2668346676253707,"score_gpt":0.4654540828694023,"score_spread":0.1986194152440316,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}